NCT01346670View on ClinicalTrials.gov

Lovastatin and Its ß-hydroxy Acid From Four 600 mg LipoCol Forte® Capsules Compared to That of One 20 mg Mevacor® Tablet in Healthy Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Healthy Volunteer
Interventions
DRUG

LipoCol and Mevacor

To evaluate the relative bioavailability of lovastatin and its ß-hydroxy acid of 600 mg LipoCol Forte® Capsules compared to that of one 20 mg Mevacor® Tablet after single oral administration in healthy subjects using a 2x2 crossover design.

Trial Locations (1)

Unknown

Taipei Medical University - WanFang Hospital, Taipei

All Listed Sponsors
lead

Taipei Medical University WanFang Hospital

OTHER

NCT01346670 - Lovastatin and Its ß-hydroxy Acid From Four 600 mg LipoCol Forte® Capsules Compared to That of One 20 mg Mevacor® Tablet in Healthy Subjects | Biotech Hunter | Biotech Hunter